Renal phosphate wasting due to overproduction of fibroblast growth factor 23 (FGF-23) in dysplastic lesions may occur in nearly 50% of patients with FD/MAS and can lead to the development of hypophosphatemia and osteomalacia ( 1 , 2 , 15 ). This evidence concerns the gene FGF23 and hypophosphatemia.